Product NDC: | 13668-132 |
Proprietary Name: | Felodipine |
Non Proprietary Name: | Felodipine |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Felodipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13668-132 |
Labeler Name: | Torrent Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202170 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111128 |
Package NDC: | 13668-132-90 |
Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-132-90) |
NDC Code | 13668-132-90 |
Proprietary Name | Felodipine |
Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-132-90) |
Product NDC | 13668-132 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Felodipine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111128 |
Marketing Category Name | ANDA |
Labeler Name | Torrent Pharmaceuticals Limited |
Substance Name | FELODIPINE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |